Standards of Input Output Norms (SION) |
Home Schedules Standards of Input Output Norms (SION) This |
|
01 - Chemical & Allied Products - Standards of Input Output Norms (SION)
|
Showing 1 to 500 of 3687 Records |
|
|
A0042 |
|
Actovegin Jelly 20% w/w (each gm. of Jelly containing De-proteinized Haemoderivative of calf's blood corresponding to 8 mg dry weight)
|
|
A0302 |
|
Deleted
|
|
A0391 |
|
Deleted
|
|
A0440 |
|
Deleted
|
|
A0776 |
|
Para Anisaldehyde/ Para Anisic Aldehyde/Anisic Aldehyde (Purity 99%)
|
|
A0794 |
|
Deleted
|
|
A1363 |
|
Hexamine
|
|
A1521 |
|
Trichloro Ethylene
|
|
A1891 |
|
Deleted
|
|
A2317 |
|
Polyamide Resins containing 77.5% of Dimer Acid
|
|
A2464 |
|
Shifted under Plastic Product Group
|
|
A2533 |
|
Uracil (Technical)
|
|
A3379 |
|
2, Acetyl Naphthalene (Beta Methyl Naphthyl Ketone)
|
|
A3380 |
|
Hydrotreating-cum-Desulphurisation Catalyst Type: G-1 Catalyst Containing: Zinc oxide 85 +/-3% and Molybdenum trioxide 3.5+/-0.3%
|
|
A3381 |
|
Deleted
|
|
A3382 |
|
5 Aceto Acetyl Amino Benximidazolone OR (5-Aceto Acetyl Amino Benzimidazolone-2)
|
|
A3383 |
|
Transformer Oil (conforming to IEC 296 class I and class II / IEC60296)
|
|
A3384 |
|
Transformer Oil high flash (Flashpoint 250º c min.)
|
|
A3385 |
|
Light Liquid Paraffin/ Light white oil / Light Mineral Oil B.P./U.S.P
|
|
A3386 |
|
Liquid Paraffin / White Oil Heavy/ Mineral Oil Heavy BP/USP (Other than covered in SION No. A-3385
|
|
A3387 |
|
Light Liquid paraffin/Light white oil / Light mineral oil
|
|
A3388 |
|
Liquid Paraffin / White Oil Heavy/ Mineral Oil Heavy (Other than covered in SION No. A-3387
|
|
A3389 |
|
Oil soluble Phenolic resin based varnish (high viscosity) (solid resin content Min. 55.7% + 2%)
|
|
A3390 |
|
Sodium salt of Trichloro Pyridinol Min.80 %
|
|
A3391 |
|
Calcium Gluconate Monohydrate
|
|
A3392 |
|
2,6 Dimethyoxy Phenol
|
|
A3393 |
|
Gatifloxsacin Hemihydrate
|
|
A3394 |
|
Lavofloxacin Hemihydrate
|
|
A3395 |
|
Celecoxib
|
|
A3396 |
|
N-(1-Oxopenthyl)-N (2-H-Tetrazol-5-YL) (1-1Biphenyl)-4- YL)-L-Valine
|
|
A3397 |
|
Methyl Gallate
|
|
A3398 |
|
Mirtazepine
|
|
A3399 |
|
Ornidazole
|
|
A3400 |
|
Flush in various colours for Printing Ink (35+/-1% Pigment and 32+/- 1% Solid Resin) other than Black, Cyan, Magenta & Yellow)
|
|
A3401 |
|
Copper & Lead Free Mirror on Float Glass
|
|
A3402 |
|
Pearl Essence Pigment (Titanium Oxide : Tio2 content =28% )
|
|
A3403 |
|
Deleted and shifted to Plastic Group
|
|
A3404 |
|
Polypropylene Multifilament Yarn (with 2% U.V. Stabilizer)
|
|
A3405 |
|
3 -Chloropropiophenone
|
|
A3406 |
|
Piperazine Di Hydrochloride
|
|
A3407 |
|
Hydrotreating - Cum - Desulphurisation Catalyst Type: G1 Catalyst containing Zinc Oxide 85+/-3% and Molybdenum Trioxide 3.5+/-0.3%
|
|
A3408 |
|
(-) Menthyl Trans- 4(4-Fluorophenyl)- N- Methyl Nipecotinate Hydrobromide
|
|
A3409 |
|
Articles made of Polyphenylene Oxide such as mounting Plate containing metallic foil and Banana Plug
|
|
A3410 |
|
Fortified Gum Rosin Dispersion containing 60% Rosin
|
|
A3411 |
|
Automobile Exhaust Catalyst Honey comb type EC 800 sizes 81.28 mm x 144.78 mm x 75.3 mm length containing Palladium content : 0.210 gm Rhodium content : 0.210 gm Cerium Oxide content : 10.6 gm and Clay Washcoat Powder : 52 gm
|
|
A3412 |
|
Automobile Exhaust Catalyst Honey comb type EC 1500 M size 132.08 mm x 78 mm Length containing : Platinum content : 0.251 gm Cerium Oxide content : 14.32 gm and Zirconium Oxide 19.67 gm
|
|
A3413 |
|
Hydro treating cum Desulphurisation catalyst Type : G-1 Catalyst containing Zinc Oxide 85+/-3% and Molybdenum Trioxide 3.5+/-0.3%
|
|
A3414 |
|
G-117 Catalyst Shape = Rib rings containing Ni-O 8% min.
|
|
A3415 |
|
Pigment Red 108 (Cadmium Red Pigmetn C.I.No. 77202 Cadmium content : 54+/-2% Selenium content : 14+/-2%
|
|
A3416 |
|
Sulphur Powder/ Roll
|
|
A3417 |
|
Leather Chemical Disodium Salt of Sulphonated containing C18 Fatty Acid 65+2% Alkyl Benzene Sulphonate 3% Heavy Alkyl 6.5% Oxo Alcohol 2.8% Chlorparaffin 4.5%
|
|
A3418 |
|
The norm covered by this entry is deleted and shifted to Plastic Group
|
|
A3419 |
|
The norm covered by this entry is deleted and shifted to Plastic Group
|
|
A3420 |
|
2,6, Dinitro-4-tertio Butyl Chlorobenzene
|
|
A3421 |
|
Di (2-Ethythexyl) Peroxy Di Carbonate 50% Purity
|
|
A3422 |
|
Reactive Blue 3GRB (Dye content 92%)
|
|
A3423 |
|
Hydrotreating - cum - Desulphurisation catalyst Type : G-1 catalyst containing Zinc Oxide 85+/-3% and Molybdenum Trioxide 3.5+/-0.3%
|
|
A3424 |
|
Direct Yellow 118 (Direct Yellow HAR P/C) (Dye content 86%)
|
|
A3425 |
|
Direct Yellow 106 (Direct Yellow EFC LF/P/C) (Dye content 77%)
|
|
A3426 |
|
BIS - (3,5,5-Trimethyl Hexanoyl) Peroxide, 75% in Odourless Mineral Spirit
|
|
A3427 |
|
Reactive Blue 221 (Reactive Blue BRX)
|
|
A3428 |
|
1-Phenyloxindole
|
|
A3429 |
|
Deleted
|
|
A3430 |
|
2, 4 Dichloro Nitro Benzene
|
|
A3431 |
|
2-Acetyl Thiophene
|
|
A3432 |
|
2, 4 D Iso Butyl Ester (Technical)
|
|
A3433 |
|
Napthol AS-LS 4-Chloro-3 Hydroxy-2 5-Dimethoxy-2-Naphthanilide C.I. No. 37555 Azoic Coupling component 23
|
|
A3434 |
|
Aqueous solution of 3-Methoxy Propylamine, 40% w/w
|
|
A3435 |
|
Antioxidant containing mixed Tert-Butyl Phenols : 25% N,N di sec butyl -p-Phenylene Diamine :75%
|
|
A3436 |
|
3-Bromo Thiophene
|
|
A3437 |
|
Direct Red 80 (Dye content 65%)
|
|
A3438 |
|
Acid Violet 90 (cololan BordeauxMB) (61% Dye content)
|
|
A3439 |
|
Sodium 2 Ethyl Hexonate
|
|
A3440 |
|
Acetyl Tributyl Citrate
|
|
A3441 |
|
Meta Chloro per Benzoic Acid (77% purity)
|
|
A3442 |
|
Flush Yellow for printing Ink (35+/-1% Pigment & 32+/-1% Solid Resin)
|
|
A3443 |
|
Pigment Alkali Blue Flush (Pigment content 40+/-2%, Solid Resin content 37+/-1%) Formaldehyde Route
|
|
A3444 |
|
Offset printing ink in Various colours other than Black, Cyan, Magenta and Yellow (Min. pigment content 14+/-1%) and Solid Resin 43+/-1%) (Flush Route)
|
|
A3445 |
|
Olefin Copolymer Viscosity Index Improver (Containing 85%+/-1% base oil and 15%+/- 1%) Ethylene Polypropylene Copolymer
|
|
A3446 |
|
Catalyst 59-5/59-M containing ZnO 36% and Na2O 17% Al2 O3 30%
|
|
A3447 |
|
Deleted
|
|
A3448 |
|
Synthetic Tanning Agent containing Sodium salt of phenol sulphonic acid polymer with formaldehyde and urea (53%) Disodium Phthalate (12%)
|
|
A3449 |
|
N-N—DI-Sec-Butyl Para Phenylenediamine]
|
|
A3450 |
|
Alpha (2, 4-Chlorophenyl) Ethyl)-alpha (1,1-dimethylethyl) 1H-1,2,4-Triazole-1-ethanol)
|
|
A3451 |
|
N-Isopropyl-N-Phenyl-P-Phenylenediamine
|
|
A3452 |
|
Tri Phenyl Phosphine
|
|
A3453 |
|
Solvent Orange3-(Chrysodine Y base)
|
|
A3454 |
|
Direct Red 239 (Dye content 68%)
|
|
A3455 |
|
Pyridine Hydrochloride
|
|
A3456 |
|
3,5-Dimethyl Piperidine
|
|
A3457 |
|
3 Acetyl Pyridine
|
|
A3458 |
|
Sodium Antimonate
|
|
A3459 |
|
Oxy Aluminium Octoate/ Aluminium Chelate (Aluminium content 5.9+/- 1%)
|
|
A3460 |
|
Alkali Blue (Pigment Blue 61) C.I. No. 42765.1
|
|
A3461 |
|
Preservative containing : i) N-Octyl Isothiozolinone (45%) 3.2%-3.4% ii) Benzimidazole Carbamate 8-10.5%
|
|
A3462 |
|
1,2,4 Trichloro Benzene
|
|
A3463 |
|
Low Voltage Porcelain Insulators of following types (Bushing, Shackle Teel, Spool, Stay Guy, Coach Screw Machine Screw, Telephone Insulators)
|
|
A3464 |
|
Dimethyl Lauryl Amine Oxide (Active matter 28-32%)
|
|
A3465 |
|
Triprolidine
|
|
A3466 |
|
N- Methyltriethanol Ammonium fatty acid Diester Methosulphate 88-90% in Isopropyl alcohol
|
|
A3467 |
|
3a 7B Dioxy Cholanic Acid
|
|
A3468 |
|
5 - Sulfo Salicylic Acid
|
|
A3469 |
|
Oryzalin technical 98% Min.
|
|
A3470 |
|
Rofecoxib
|
|
A3471 |
|
Di Calcium Phosphate Anhydrous
|
|
A3472 |
|
Amorphous Cefuroxime Axetil
|
|
A3473 |
|
Sodium Cyanate
|
|
A3474 |
|
Pigment Phthalocyanine Blue 15:3
|
|
A3475 |
|
Phenoxy Acetic Acid
|
|
A3476 |
|
N-Methylol Stearamide
|
|
A3477 |
|
Pigment Red 48:3 (C.I. No. 15865:3)
|
|
A3478 |
|
Heat Resistant Latex Rubber Thread - Coloured
|
|
A3479 |
|
Ethoxylated Lauryl Alcohol 2 moles
|
|
A3480 |
|
Ethoxylated Lauryl Alcohol 3 moles
|
|
A3481 |
|
PVC Stabilizer PA-804 (Lead content 38+/-1%) containing: Tribasic Lead Sulphate 25+/-1%, Dibasic Lead Stearate + Lead Stearate mixture 42+/-1%, Wax 33+/-1%
|
|
A3482 |
|
Meta Phenylene Diamine
|
|
A3483 |
|
Polyurethane Wheels
|
|
A3484 |
|
Benzathine Penicillin G
|
|
A3485 |
|
8-Choloro-10,11 Dihydro-4-Aza-Dibenzo (A,D)-Cycloheptan-5-One
|
|
A3486 |
|
Cineole
|
|
A3487 |
|
(1,2 Ethandiylbis (Oxy) bis Methanol)/1,6 Dihydroxy Dioxahaxane
|
|
A3488 |
|
Paracetamol through Para Amino Phenol Route
|
|
A3489 |
|
Synthetic Tanning Agent (Neo syn 5WB) Containing Sodium Salt of Phenol Sulphonic Acid Polymer with Formaldehyde and Urea (53%) Disodium Phthalate (12%)
|
|
A3490 |
|
Amiloride Hydrochloride BP/USP
|
|
A3491 |
|
Phenyl Ethyl Methyl Ether
|
|
A3492 |
|
Pigment Red 49:1 (C.I.No. 15630: 1)
|
|
A3493 |
|
PVC Tin -Stabilizer (Shitastap 121) (Containing: 34+/- 2% of Mono Octyl Tin 2-Ethylhexyl Thioglycolate & 66+/- 2% of Di Octyl Tin 2 Ethyl Hexyl Thioglycolate
|
|
A3494 |
|
Direct Reduction 1 reforming catalyst Type DRC-07 RWH Nickel content: 7.5 9% (w/w) Bulk density: 1 kg per litre
|
|
A3495 |
|
G-31E Catalyst (from extrusion) containing Nickel content 8.4% w/v Bulk Density: 1.2 kg/Litre
|
|
A3496 |
|
Medical X-Ray Film in various Sizes
|
|
A3497 |
|
PVC Stabiliser PA 8009 (lead content : 25+/-1%), containing: Tri basic lead sulphate 22+/-1% Di Basic lead stearate +lead stearate mixture 37 +/-1% Polyethylene wax 20+/-1% paraffin wax 21+ /-1% Bisphenol A 0.1%
|
|
A3498 |
|
Phenazopyridine Hyrochloride USP
|
|
A3499 |
|
Lenacil Technical 98% Min. (3-Cyclohexyl-5,6-Trimethylene uracil)
|
|
A3500 |
|
Tabcoat TC Containing Hydroxy Propyl Methyl Cellulose 66% Titanium Dioxide 18.5%
|
|
A3501 |
|
OT 33 Insoluble Sulphur Containing average 67% elemental sulphur & average oil content 33%
|
|
A3502 |
|
Catalyst Type : 125-1-01 containing Zinc Oxide 49+/-2%
|
|
A3503 |
|
Nitro Phenyl Mercapto Aniline
|
|
A3504 |
|
Ciprofloxacin HCL
|
|
A3505 |
|
Preservative containing N-Octyl Isothiozolinone (45%) 3.2%-3.4%, Benzimidazole Carbamate 8-10.5% and N (N,N Di-Methyl Amino Carbonyl) 3,4 Dichloro Aniline 20-22%
|
|
A3506 |
|
Methoxyamine Hydrochloride
|
|
A3507 |
|
Ethoxy Amine
|
|
A3508 |
|
Nitrile Butadiene Rubber (with bound acrylonitrile content 33+/-1% & DOP 35% extended)
|
|
A3509 |
|
Sodium Mercapto-benzothiazole 50% munimum
|
|
A3510 |
|
Methyl -2-chloro Phenyl acetate (Methyl Orthochloro Phenyl Acetate Or 2- chloro phenyl acetate methyl Ester or Ortho Chloro Phenyl acetate methyl ester)
|
|
A3511 |
|
2,4 Dichloro Phenyl Acetic Acid
|
|
A3512 |
|
Disodium Lauryl sulfossuccinate Powder/ Needles/ Granules
|
|
A3513 |
|
Readymix for manufacturing Transparent combi body wash containing 20% of Sodium Lauryl Ether Sulfate (70%) 8% of coco anmidopropyl betaine (active matter 29%) 18% of Sodium Stearate 10% of Sodium Cocoate 3% free acid each of coconut fatty acid and stearic acid and 24% of Humectants as (Propylene Gly
|
|
A3514 |
|
Para Xylene Dimethyl Ether
|
|
A3515 |
|
Deleted, already appears in the entry at S.No. A3487
|
|
A3516 |
|
Para Chloro Benzyl Cyanide 75% Solution in N-butyl Acetate (4-Chloro Benzyl Cyanide 75% Solution in N-butyl Acetate)
|
|
A3517 |
|
3,4,4-trichloro Carbanilide
|
|
A3518 |
|
N-Di Cyclohexyl 2 Benzothiazole Sulphenamide (DCBS)
|
|
A3519 |
|
Venlafaxine Hcl
|
|
A3520 |
|
Moxifloxacin Hcl
|
|
A3521 |
|
Nelfinavir Mesylate
|
|
A3522 |
|
Clopidogrel Bisulphate
|
|
A3523 |
|
1-[(2-amino-1(4-Methoxy phenyl) ethyl)] cyclohexanol HCL
|
|
A3524 |
|
(4R,6R) -6-[2-[(1S,2S, 6R, 8S,8AR)-1,2,6,7,8,8-A-Hexahydro-8-(2,2-dimethyl-1-Oxobutoxy)-2,6-Dimethyl-1-Naphthyl]Ethyl] tetrahydro-4-Hydroxy-Butyloxy-2H-Pyran-2-one
|
|
A3525 |
|
Nevirapine
|
|
A3526 |
|
Sertraline HCL
|
|
A3527 |
|
N-Triphenyl Methyl-2-amino ethanol
|
|
A3528 |
|
Butyl and EPDM Tubes other than Cycle Tubes containing minimum 13% EPDM Rubber
|
|
A3529 |
|
Simethicone (Formulation with varying active substance)
|
|
A3530 |
|
Activated Polydimethyl Siloxane (Simethicone USP)
|
|
A3531 |
|
Ethylene Oxide
|
|
A3532 |
|
Potassium Acetate Anhydrous
|
|
A3533 |
|
Methyl Ethyl Ketone Peroxide 50% w/w min. in Dimethyl Phthalate (Active Oxygen content 9% Min.)
|
|
A3534 |
|
1,2 Ethandiylbis (oxy ) bis Methanol / 1,6 Dihydroxy Dioxahexane
|
|
A3535 |
|
Preservative Mixture of Condensate of Ethylene Glycol formaldehyde (46.5-47.5%) and Chloro Methyl Isothiozolinone (0.75%-0.82%)
|
|
A3536 |
|
Preservative containing 1) 5.3% of 1,2 Benzoisothiazoline-3-one paste (75%) 2) 61% of 1,3,5 Tris (2-Hydroxyethyl)-hexahydrotriazine
|
|
A3537 |
|
Butyl Methoxy Dibenzoyl Methane
|
|
A3538 |
|
2-Acrylamido-2-Methyl Propane Sulfonic Acid (purity minimum 99%)
|
|
A3539 |
|
Glyceryl Mono-oleate
|
|
A3540 |
|
Fast Red B Base 4 Nitro Ortho Anisidine
|
|
A3541 |
|
Synthetic Slippers / Sandals with PU Sole of all sorts
|
|
A3542 |
|
Quinine Bisulphate BP/ USP/EP
|
|
A3543 |
|
Quinine Base BP/USP/EP
|
|
A3544 |
|
Glyphosate 41% SL (IPA salt)
|
|
A3545 |
|
Calcium Carbide
|
|
A3546 |
|
10- Deacetyl Baccatin - III
|
|
A3547 |
|
Ortho Cresyl Glycidyl Ether
|
|
A3548 |
|
Sodium Metaperiodate
|
|
A3549 |
|
Cheque Security Paper (MICR/Non-MICR)
|
|
A3550 |
|
Tetrabenzyl Cyclen
|
|
A3551 |
|
Cyclen
|
|
A3552 |
|
Ready to assemble office Furniture system/ Modular Furniture/ Storage System/ Computer furniture/ Drawer Unit/Drawer Trolly/ work station/ Student Studio/Filing Cabinet/ Cupboard/ Book Case/ Sliding Door Unit etc.
|
|
A3553 |
|
Sodium Selenate
|
|
A3554 |
|
Optical Brightener (C.I.Fluorescent Brightener 220)(assay 25%)
|
|
A3555 |
|
Paramethoxy Ethyl phenol (4-(2-Methoxy Ethyl) Phenol
|
|
A3556 |
|
Propiconazole Technical (1-2(2,4-Dichlorophenyl 4 Propyl-1, 3-Dioxolane-2-yl) Methyl)-1H -1,2,4 Triazole) (A.1 88% Min).
|
|
A3557 |
|
Para Nitro Cumene
|
|
A3558 |
|
Ethyl Acrylate (Acrylonitrile Route)
|
|
A3559 |
|
1,3-Butadiene
|
|
A3560 |
|
Methyl Acrylate (Acrylonitrile Route)
|
|
A3561 |
|
Titanium dioxide (Rutile)
|
|
A3562 |
|
Topiramate
|
|
A3563 |
|
Carvedilol
|
|
A3564 |
|
Carbamazepine BP/USP
|
|
A3565 |
|
Benzyl Salicylate
|
|
A3566 |
|
Eosine (C.I.No. 45380) (Dye content: 90%)
|
|
A3567 |
|
Copper Sulphate 20% WP (Bordeaux Mixture 20% WP) (Copper Content 20%)
|
|
A3568 |
|
Fenpropathrin Technical
|
|
A3569 |
|
Dist. Fatty Acids (C8-C18) Derived from Palm Kernel Oil
|
|
A3570 |
|
Dist. Fatty Acids (C16-C18) Derived from Palm Stearine
|
|
A3571 |
|
Optical Brightener Bluton BA LIQ (C.I. Fluorescent Brightener 113) (Assay 20%)
|
|
A3572 |
|
Optical Brightener C.I Fluorescent Brightener 71 (Assay 97%)
|
|
A3573 |
|
Montelukast Sodium
|
|
A3574 |
|
Lauric Mono Ethanol Amide (active content 96% min.)
|
|
A3575 |
|
Pre-reforming Catalyst containing NiO 46% A1203 33% and Cr.203 1.6%
|
|
A3576 |
|
Preservative containing Chloromethyl Isothiozolinone content 8.4% (Min) & Methyl Isothiozolinone 2.5% (Min.)
|
|
A3577 |
|
Beta [(1H-1, 2,4- Triazol-1-yl)methyl]- 2,4-dichloro benzene ethanol (M Alcohol)
|
|
A3578 |
|
Prinstol/Alurol-MW- 1/Alurol-Prime Base
|
|
A3579 |
|
Optical Brightener Fluorescent Brightener Bluton UBR Liquid (Assay 22%)
|
|
A3580 |
|
Optical Brightener Tinopal UP Liquid(C.I. Fluorescent Brightener 113) (Assay 22%)
|
|
A3581 |
|
Optical Brightening Agent C.I. Fluorescent 251 (Assay 24%)
|
|
A3582 |
|
Optical Brightening Agent C.I. Fluorescent Brightener 252 (Assay 90%)
|
|
A3583 |
|
Optical Brightening Agent C.I. Fluorescent Brightener 353 (Assay 54%)
|
|
A3584 |
|
Optical Brightening Agent C.I. Fluorescent Brightener 90 (Assay 33.5%)
|
|
A3585 |
|
Optical Brightener Agent C.I. Fluorescent Brightener-252 (Assay 33%)
|
|
A3586 |
|
Optical Brightener C.I. Fluorescent Brightener 362 (Assay 29.5%)
|
|
A3587 |
|
Abacavir Sulphate
|
|
A3588 |
|
Alprazolam
|
|
A3589 |
|
3,3,5-Trimethyl Cyclohexanol
|
|
A3589 |
|
3,3,5-Trimethyl Cyclohexanol
|
|
A3590 |
|
Benzyl Salicylate
|
|
A3591 |
|
Phenyramidiol Hcl
|
|
A3592 |
|
Polishing Compound, Rouge AA (containing Synthetic Ferric Oxide Min. 88.2%) and Stearic Acid min. 10%
|
|
A3593 |
|
Optical Brightening Agent (C.I. Fluorescent Brightener 113) (Assay 32%)
|
|
A3594 |
|
Fluorescent Flushed Ink Concentrate General Green (Amino Sulphonamide content 47%)
|
|
A3595 |
|
Fluorescent Flushed Ink Concentrate Saturn Yellow (Amino Sulphonamide content 47%)
|
|
A3596 |
|
Fluorescent Pigment Red Orange (Amino Sulphonamide Matrix content 95%)
|
|
A3597 |
|
Fluorescent Ink Concentrate BLUE IV - Invisible Euroblue (Amino Sulphonamide Based matrix content 48%)
|
|
A3598 |
|
deleted
|
|
A3599 |
|
5% Palladium on carbon Catalyst
|
|
A3600 |
|
Fluorescent Pigment Yellow HTPA (Polyester Matrix content 95%)
|
|
A3601 |
|
Fluorescent Pigment Red HTPA (Polyester Matrix content 95%)
|
|
A3602 |
|
Fluorescent Pigment Magenta HTPA (Polyester Matrix content 95%)
|
|
A3603 |
|
Fluorescent Pigment Violet HTPA (Polyester Matrix content 95%)
|
|
A3604 |
|
Fluorescent Pigment Royal Blue HTPA (Polyester Matrix content 95%)
|
|
A3605 |
|
Para Floro Aniline
|
|
A3606 |
|
Clorsulon (4-Amino-6(trichlorovinyl)-m-benzendisulfonamide)
|
|
A3607 |
|
Toldimfos Sodium
|
|
A3608 |
|
Nitroxynil
|
|
A3609 |
|
Dextropropoxyphene base
|
|
A3610 |
|
Palm Fatty Acid Diamine
|
|
A3611 |
|
Optical Whitening Agent Optical Brightner CF 200% (Assay 33.5%) C.I. No. Fluorescent Brighter 090
|
|
A3612 |
|
Potassium Iodide 100% basis
|
|
A3613 |
|
Cupric Chloride Dihydrate
|
|
A3614 |
|
Mono Methyl Aniline
|
|
A3615 |
|
Zinc Salt of 2 Mercapto Benzothiazole (Active Content 93%)
|
|
A3616 |
|
Mono Methyl Amine Hydrochloride
|
|
A3617 |
|
Dimethyl Urea
|
|
A3618 |
|
Alpha Naphthol
|
|
A3619 |
|
Optical Brightener AMP Liquid (Assay 27%)
|
|
A3620 |
|
Optical Brightener/Optical Whitening Agent (Fluorescent Brightener 208) (Assay 72%)
|
|
A3621 |
|
4-Methoxy Phenyl Acetone
|
|
A3622 |
|
Mirtazapine (From 1-Methyl 3 phenyl piperazine route
|
|
A3623 |
|
2-Bromopyridine
|
|
A3624 |
|
2,6 Dichloropyridine
|
|
A3625 |
|
Lube Oil Base Stock - 500 N ( LOBS)
|
|
A3626 |
|
3a 7b Dihydroxy
|
|
A3627 |
|
Glass Vials / Phials / Ampoules / Perfume Bottles / Nail Enamel Bottles /Foundation Bottles/ Miniatures / Cream Jars (Glass Scrap/Cullet route)
|
|
A3632 |
|
Quinine Hydrochloride BP/USP/EP
|
|
A3633 |
|
Ethylene Glycol Mono Ethyl Ether Acetate
|
|
A3634 |
|
Diethylene Glycol Mono Ethyl Ether
|
|
A3635 |
|
Diethylene Glycol Mono Ethyl Ether Acetate
|
|
A3639 |
|
Propylene
|
|
A3640 |
|
Verdyl Acetate
|
|
A3640 |
|
Verdyl Acetate
|
|
A3641 |
|
Verdyl Propionate
|
|
A3642 |
|
Amyl Salicylate
|
|
A1445 |
|
Para Chloro Benzoic Acid
|
|
A0001 |
|
Deleted
|
|
A0002 |
|
1,(4-Hydroxy 3- Hydroxy Methyl Phenyl) 2-(N-Terbutyl-N-Benzyl Amino) Ethanol (Drug Intermediate of Salbutamol Sulphate)
|
|
A0003 |
|
1,2-Dihydro 2-Oxyquinoxaline
|
|
A0004 |
|
1-(2,6-Dichlorophenyl)-2-Indolinone
|
|
A0005 |
|
1-(2-Propenyl)-1, 3-Dihydro-2-H Benzimidazol-2- One(Minimum 99% Purity)
|
|
A0006 |
|
1-(3-Chloropropyl)-2-Benzimidazoline
|
|
A0007 |
|
1-(4-Fluorobenzyl) 2-Chloro Benzi- midazole
|
|
A0008 |
|
1-(4-Piperidinyl)- 5-Chloro-2-Benzi- midazolinone
|
|
A0009 |
|
1-(Paratolyl)-3-Methyl-5-Pyrazolone
|
|
A0010 |
|
1-Ethyl-6-Fluoro-7-Chloro 1, 4-Di-Butyro-4-oxo quinoline-3-carboxylic Acid (Norfloxacin Intermediate)
|
|
A0011 |
|
1-Methylamine 1-Methi-thio-2 Nitroethane Nitro compound
|
|
A0012 |
|
1-Phenyl 3-Methyl- 5 Pyrazolone (PMP)
|
|
A0013 |
|
1-[2-(4-Methoxy Phenyl) Ethyl]- 4-Aminopiperidine Dihydrochloride
|
|
A0014 |
|
2 Amino-5(N-Ethyl-N(2-Methane Sulfonamide Ethyl) Aminotoluene Sesquisulphate Monohydrate
|
|
A0015 |
|
2 Mercapto Benzimidazole
|
|
A0016 |
|
2 Morpholino, 2,3 Dihydro 3,3 Dimethyl Benzo- furane Methyl Sulphonate
|
|
A0017 |
|
2, Morpholino 2,3-Dihydro 3,3-Dimethyl Benzofuranyl Methyl Sulphonate
|
|
A0018 |
|
2,4 Di-Chloro Phenacyl Chloride (2,2,4- Tri-Chloro Aceto Phenone)
|
|
A0019 |
|
2-Amino Thio Phenol
|
|
A0020 |
|
2-Chloro Benzimidazole
|
|
A0021 |
|
2-Methyl-5-Nitro lmidiazole
|
|
A0022 |
|
Deleted
|
|
A0023 |
|
Deleted
|
|
A0024 |
|
3,4,5 Trimethoxy Benzoic Acid Methyl Easter
|
|
A0025 |
|
3,5 Dinitro Ortho Toluamide (98%)
|
|
A0026 |
|
CMIC Chloride
|
|
A0027 |
|
4,4 Diamino Diphenyl Sulphone BP/ Dapsone BP
|
|
A0028 |
|
4,4-Oxybis (Benzene Sulfonyl Hydrazide)
|
|
A0029 |
|
4-Bromo 2-Fluoro Biphenyl
|
|
A0030 |
|
5-Amino Salicylic Acid
|
|
A0031 |
|
5-Bromo Nicotinic Acid
|
|
A0032 |
|
Deleted
|
|
A0033 |
|
6-APA
|
|
A0034 |
|
Deleted
|
|
A0035 |
|
7-ADCA (Enzymatic Route)
|
|
A0036 |
|
7-Chloro-6-Fluoro- 1-Cyclopropyl-1-4- Dihydro-4-Oxoqui- noline-3-Carb- oxilic Acid (Drug intermediate for Ciprofloxacin)
|
|
A0037 |
|
7-Dehydro Cholestrol (100% purity)
|
|
A0038 |
|
Acetazolamide
|
|
A0039 |
|
Acetyl Salicylic Acid
|
|
A0040 |
|
Acriflavin/ Acriflavin Hydrochloride/ Acriflavin neutral BPC/ Eu-Flavin NFX/Proflavin Hemisulphate
|
|
A0041 |
|
Actovegin Injection 5 ml Ampoule containing Actovegin concentrate not less than 1113 mg
|
|
A0043 |
|
Actovegin Ointment 5% W/W. (each gm. of ointment containing:Deproteinized Haemoderivative of calf's blood corresponding to 2 mg. dry weight
|
|
A0044 |
|
Adrenaline Injection (Adrenaline Tartrate Injection) - 100 ml bottle (Each 100 ml contains Adrenaline acid Tartrate 180 mg equivalent to 100 mg of Adrenaline)
|
|
A0045 |
|
Albendazole USP/EP
|
|
A0046 |
|
Deleted
|
|
A0047 |
|
Amino Acrylate (2,4- dichloro-5- Flouro Cyclopropyl Amino Acrylate)
|
|
A0048 |
|
Amino Methyl Piperazine
|
|
A0049 |
|
Deleted
|
|
A0050 |
|
Amodiaquine base
|
|
A0051 |
|
Deleted
|
|
A0052 |
|
Amodiaquine Tablets 200 mg (each tablet contains Amodiaquine Hydrochloride equivalent to 200 mg of Amodiaquine)
|
|
A0053 |
|
Deleted
|
|
A0054 |
|
Amoxycilin Capsules 250 mg (Each capsule containing Amoxycllin Trihydrate equivalent to 250 mg of Amoxycillin)
|
|
A0055 |
|
Deleted
|
|
A0056 |
|
Amoxycillin oral suspension (Amoxycillin Syrup) 125 mg/5 ml, 60 ml bottle (Each 5 ml contains Amoxycillin Trihydrate equivalent to 125 mg of Amoxycillin)
|
|
A0057 |
|
Amoxycillin Trihydrate
|
|
A0058 |
|
Amoxycillin Trihydrate (Pen G Route)
|
|
A0059 |
|
Ampicillin and Cloxacillin Capsules (250 mg +250 mg) (Each capsule contains Ampicillin Trihydrate equivalent to 250 mg of Ampicillin and Cloxacillin Sodium equivalent to 250 mg of Cloxacillin)
|
|
A0060 |
|
Ampicillin Anhydrous BP/USP
|
|
A0061 |
|
Deleted
|
|
A0062 |
|
Ampicillin Capsules 250 mg each capsule containing ampicillin trihydrate equivalent to 250 mg. ampicillin base
|
|
A0063 |
|
Deleted
|
|
A0064 |
|
Deleted
|
|
A0065 |
|
Ampicillin injection-250 mg (Ampicillin Sodium Injection) (Each vial contains Ampicillin Sodium equivalent to Ampicillin 250 mg)
|
|
A0066 |
|
Ampicillin oral suspension (Ampicillin Syrup) 125 mg/5 ml, 60 ml bottle (each 5 ml contains Ampicillin Trihydrate equivalent to 125 mg of Ampicillin )
|
|
A0067 |
|
Ampicillin Sodium Sterile
|
|
A0068 |
|
Ampicillin Trihydrate (6APA Route)
|
|
A0069 |
|
Ampicillin Trihydrate (Pen G Route)
|
|
A0070 |
|
Analgin
|
|
A0071 |
|
Analgin (from PMP Route)
|
|
A0072 |
|
Analgin Injection-5 ml ampoules (Each ml. containing 500 mg of analgin)
|
|
A0073 |
|
Analgin Tablets-500 mg
|
|
A0074 |
|
Anisole
|
|
A0075 |
|
Antipyrine Salicylate (Phenazone Salicylate)
|
|
A0076 |
|
Aspartame Sugar Free Tablets (Each tablet containing not less than 18 mg Aspertame)
|
|
A0077 |
|
Aspirin Tablets-300 mg (Acetyl Salicylic Acid Tablets) (From Phenol stage )
|
|
A0078 |
|
Deleted
|
|
A0079 |
|
Atenolol BP/USP
|
|
A0080 |
|
Deleted
|
|
A0081 |
|
Beclomethasone Dipropionate 200 MD Inhaler (each mitered Inhalaion supplied contain Beclomethasone Dipropionate 50 mcg)
|
|
A0082 |
|
Deleted
|
|
A0083 |
|
Deleted
|
|
A0084 |
|
Betamethasone Dipropionate BP 93/ USP 23
|
|
A0085 |
|
Betaionone 92%
|
|
A0086 |
|
Betamethasone + Neomycin Skin Ointment (Each gram contains Betamethasone Dipropionate USP 0.064% W/W and Neomycin Sulphate BP 0.5% W/W)
|
|
A0087 |
|
Betamethasone Dipropionate cream (each gram contains Betamethasone Dipropionate equivalent to 0.05% w/w of Betamethasone)
|
|
A0088 |
|
Betamethasone valerate Ointment with Gentamycin Sulphate (Composition: Betamethasone valerate 0.122% and Gentamycin Sulphate 0.1% by weight)
|
|
A0089 |
|
Betamethasone Valerate Ointment/Cream (containing Betamethasone Valerate 0.12% w/w equivalent to 0.10% w/w of Betamethasone and 0.5% w/w of Neomycin Sulphate IP)
|
|
A0090 |
|
Betamethasone Valerate Ointment/Cream(containing Beta Methasone Valerate 0.12% w/w Equivalent to 0.10% w/w of Betamethasone)
|
|
A0091 |
|
Bi-Penicillin 1 Mega Injection
|
|
A0092 |
|
BIS (2-Chloro Ethyl) Amine Hydrochloride
|
|
A0093 |
|
Bisacodyl
|
|
A0094 |
|
Bromhexine Hydrochloride BP
|
|
A0095 |
|
Bromochlorophen
|
|
A0096 |
|
Bromocriptine tablets 2.5 mg (each tablet contains Bromocriptine Mesylate equivalent to 2.5 mg of Bromocriptine
|
|
A0097 |
|
Caffeine
|
|
A0098 |
|
Calcium Glycerophosphate BPC
|
|
A0099 |
|
Calcium Glycerophosphate NFX
|
|
A0100 |
|
Calcium Lactate Pentahydrate USP
|
|
A0101 |
|
Calcium Sennocides A&B Powder
|
|
A0102 |
|
Captopril 50 mg. tablets from D-Amide stage
|
|
A0103 |
|
Captopril USP (Powder)
|
|
A0104 |
|
Captopril USP (Powder)(from D-Amide stage)
|
|
A0105 |
|
Captoprill USP
|
|
A0106 |
|
Carboplatin
|
|
A0107 |
|
Deleted
|
|
A0108 |
|
Cefadroxil
|
|
A0109 |
|
Cefadroxil(from 7-ADCA Route)
|
|
A0110 |
|
Cefazolin Sodium Injection USP, 1gm/10 ml vial (each vial containing not less than 1 gm of Cefazolin)
|
|
A0111 |
|
Deleted
|
|
A0112 |
|
Deleted
|
|
A0113 |
|
Cephalexin Capsules-250 mg. (Each capsule containing Cephalexin equivalent to 250 mg of anhydrous Cephalexin )
|
|
A0114 |
|
Cephalexin Monohydrate
|
|
A0115 |
|
Deleted
|
|
A0116 |
|
Cephalexin Monohydrate (from Pen G Stage)
|
|
A0117 |
|
Cetrimide BP 88
|
|
A0118 |
|
Chloramphenicol
|
|
A0119 |
|
Chloramphenicol Capsules 250 mg
|
|
A0120 |
|
Chloramphenicol oral suspension 60 ml bottle (each 5 ml contains Chloramphenicol Palmitate equivalent to 125 mg of Chloramphenicol)
|
|
A0121 |
|
Chloramphenicol Palmitate
|
|
A0122 |
|
Chloramphenicol Sodium Succinate Injection (0.3 gm /vial) (each vial contains Chloramphenicol Sodium Succinate equivalent to 0.3 gm of Chloramphenicol)
|
|
A0123 |
|
Chloramphenicol Sodium Succinate Sterile
|
|
A0124 |
|
Chloramphenicol Stearate
|
|
A0125 |
|
Chlordiazepoxide Hydrochloride Tablets-5 mg (each tablet contains chlordiazepoxide Hydrochloride equivalent to 5 mg of Chlordiazepoxide )
|
|
A0126 |
|
Chlorhexidine Acetate
|
|
A0127 |
|
Chlorhexidine Base
|
|
A0128 |
|
Chlorhexidine Gluconate 20% Solution
|
|
A0129 |
|
Chlorhexidine Hydro Chloride
|
|
A0130 |
|
Chlorobutol Hemihydrate USP/ BP/ NF
|
|
A0131 |
|
Chlorohydroxy Quinoline 60%
|
|
A0132 |
|
Chlorophenesin BP
|
|
A0133 |
|
Chlorophenesin Carbamate
|
|
A0134 |
|
Chloroquine Phosphate injection (200 mg/5 ml) 5 ml ampoules (each 5 ml contains Chloroquine phosphate equivalent to 200 mg. of Chloroquine base)
|
|
A0135 |
|
Chloroquine Sulphate injection (200 mg./5 ml) 5 ml ampoules (each 5 ml contains Chloroquine Sulphate equivalent to 200 mg. of Chloroquine base)
|
|
A0136 |
|
Chlorpheniramine Maleate
|
|
A0137 |
|
Chlorpheniramine Maleate BP 88/USP 21
|
|
A0138 |
|
Chlorpropamide
|
|
A0139 |
|
Ciprofloxacin Hcl / Base
|
|
A0140 |
|
Cis + Hydroxy Lactam/Cis (+)-2-(4-Methoxy Phenyl)-3-Hydroxy-2, 3-Dihydro-1,5-Benzothiazephin-4-(5H)-one
|
|
A0141 |
|
Cisapride Monohydrate BP
|
|
A0142 |
|
Cisplatin
|
|
A0143 |
|
Clemastine Hydrogen Fumarate
|
|
A0144 |
|
Clotrimazole
|
|
A0145 |
|
Cloxacillin Capsules 250 mg
|
|
A0146 |
|
Deleted
|
|
A0147 |
|
Cloxacillin capsules-250 mg (Each capsule contains Cloxacillin Sodium equivalent to 250 mg of Cloxacillin)
|
|
A0148 |
|
Cloxacillin capsules-250 mg (Each capsule contains Cloxacillin Sodium equivalent to 250 mg of Cloxacillin) (From 6 APA stage)
|
|
A0149 |
|
Cloxacillin Injection (250 mg/vial) Each vial contains Cloxacillin Sodium equivalent to 250 mg of anhydrous cloxacillin)
|
|
A0150 |
|
Cloxacillin oral solution (Cloxacillin syrup) 125 mg/5 ml, 60 ml. bottle (each 5 ml contains cloxacillin sodium equivalent to 125 mg of cloxacillin)
|
|
A0151 |
|
Cloxacillin Sodium (From 6 APA route)
|
|
A0152 |
|
Cloxacillin Sodium (from Pen G Stage)
|
|
A0153 |
|
Cotrimoxazole Tablets (Each tablet containing 80 mg of Trimethoprim and 400 mg of Sulphamethoxazole)
|
|
A0154 |
|
Crude Sodium Theophylline
|
|
A0155 |
|
Cyclopropyl Amine
|
|
A0156 |
|
Cyclopropyl Amine
|
|
A0157 |
|
D (+) Acid
|
|
A0158 |
|
Deleted
|
|
A0159 |
|
Deleted
|
|
A0160 |
|
D(-) Alpha Phenyl Glycine Ethyl Potassium Dane Salt (Toluene Route)
|
|
A0161 |
|
Deleted
|
|
A0162 |
|
D(-)Alpha Phenyl Glycine Base (From Toluene Route)
|
|
A0163 |
|
D(-)Alpha Phenyl Glycine Chloride Hcl (from Toluene Route)
|
|
A0164 |
|
D(-)Alpha Phenyl Glycine Chloride Hydrochloride
|
|
A0165 |
|
D-2-Aminobutanol
|
|
A0166 |
|
D-Oxyphene Base (Powder)
|
|
A0167 |
|
Danazol
|
|
A0168 |
|
Debrisoquine tablets 10 mg (Each tablet contains Debrisoquine sulphate equivalent to 10 mg of Debrisoquine)
|
|
A0169 |
|
Dehydrated Culture media (Agar media/Broth media)
|
|
A0170 |
|
Dehydro Pregnenolone Acetate (16-DPA)
|
|
A0171 |
|
Dexamethasone and Neomycin Eye/Ear drops containing 0.5% W/V Neomycin and Dexamethasone Sodium Phosphate USP 0.1%. W/V
|
|
A0172 |
|
Dexamethasone Disodium Phosphate USP
|
|
A0173 |
|
Dextromethorphan Hydrobromide
|
|
A0174 |
|
Dextromethorphan Hydrobromide
|
|
A0175 |
|
Dextropropoxy phene Napsylate BP/USP
|
|
A0176 |
|
Dextropropoxyphene Hydrochloride
|
|
A0177 |
|
Di-cloxacillin Sodium
|
|
A0178 |
|
Di-iodohydroxy quinoline
|
|
A0179 |
|
Di-phenyl Aceto Nitrile
|
|
A0180 |
|
Diazepam B.P.
|
|
A0181 |
|
Diazepam Tablets 5 mg (From Benzylcyanide stage)
|
|
A0182 |
|
Deleted
|
|
A0183 |
|
Dichlorophen BP
|
|
A0184 |
|
Dichlorophen (Technical)
|
|
A0185 |
|
Deleted
|
|
A0186 |
|
Deleted
|
|
A0187 |
|
DICMIC Chloride
|
|
A0188 |
|
Diethyl Carbamazine Citrate
|
|
A0189 |
|
Diloxanide Furoate
|
|
A0190 |
|
Diloxanide Furoate BP (Hydroquinone Route)
|
|
A0191 |
|
Diltiazem HCl
|
|
A0192 |
|
Dimetridazole BP Vet
|
|
A0193 |
|
Diphenhydramine HCL
|
|
A0194 |
|
Diphenyl Guanidine Powder
|
|
A0195 |
|
Diphenyl Hydantoin
|
|
A0196 |
|
Diphenyl Hydantoin Sodium
|
|
A0197 |
|
DL Naproxen
|
|
A0198 |
|
DL(Racemic) Chloramphenicol
|
|
A0199 |
|
DL-Alpha Tocopherol Acetate PH EUR (Vitamin E Acetate)
|
|
A0200 |
|
DMCA purified (3 Beta, 5-alpha- dihydroxy - 17 alpha methoxy- 17 Beta Carbomethoxy androstand 6-one)
|
|
A0201 |
|
DMF Solvate
|
|
A0202 |
|
Domperidone
|
|
A0203 |
|
Domperidone Maleate
|
|
A0204 |
|
Doxycycline capsules-50 mg. (each capsule containing Doxycycline Hydrochloride equivalent to 50 mg. Doxycycline)
|
|
A0205 |
|
Drug Formulations Injections(ampules/ vials upto 10 ML)
|
|
A0206 |
|
Drug Formulations Injections(ampules/ vials above 10 ML)
|
|
A0207 |
|
Drug Formulations Syrups
|
|
A0208 |
|
Dry syrup Ampicillin +Cloxacillin (125 mg/5 ml + 125 mg/5 ml) 60 ml bottle (each 5 ml contains ampicillin Trihydrate equivalent to 125 mg of Ampicillin and cloxacillin Sodium equivalent to 125 mg of cloxacillin)
|
|
A0209 |
|
Empty Hard Gelatin Capsules
|
|
A0210 |
|
Enalapril Maleate
|
|
A0211 |
|
Enalapril Maleate 2.5 Mg. Tablets
|
|
A0212 |
|
Enrofloxacin
|
|
A0213 |
|
Enzyme Acylase
|
|
A0214 |
|
Ephedrine Hydrochloride B.P./U.S.P.
|
|
A0215 |
|
Erythromycin BP 88
|
|
A0216 |
|
Erythromycin Estolate B.P.88
|
|
A0217 |
|
Erythromycin Estolate capsules-250 mg (Each capsule contains Erythromycin Estolate equivalent to 250 mg of Erythromycin )
|
|
A0218 |
|
Erythromycin Estolate for Oral Suspension 125 mg/ 5 ml- 100 ml bottle (Each 5 ml containing Erythromycin Estolate equivalent to 125 mg. of Erythromycin)
|
|
A0219 |
|
Erythromycin Ethyl Succinate BP/ USP
|
|
A0220 |
|
Erythromycin Stearate 250 mg Tablet (each Tablet containing Erythromycin Stearate equivalent to 250 mg of Erythromycin)
|
|
A0221 |
|
Erythromycin Stearate BP-88
|
|
A0222 |
|
Erythromycin Stearate tablets-250 mg (each tablet contains erythromycin stearate equivalent to 250 mg of Erythromycin)
|
|
A0223 |
|
Estramustine Sodium Phosphate BP
|
|
A0224 |
|
Estrenon Crude
|
|
A0225 |
|
Ethambutol HCL
|
|
A0226 |
|
Deleted
|
|
A0227 |
|
Ethambutol Tablets 400 mg
|
|
A0228 |
|
Ethopabate (VET)'93
|
|
A0229 |
|
Etophylline
|
|
|
........ |
|
|